Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication

• Giuseppe Balistreri ,

  Contributed equally to this work with: Giuseppe Balistreri, Johanna Viiliäinen

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Johanna Viiliäinen ,

  Contributed equally to this work with: Giuseppe Balistreri, Johanna Viiliäinen

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Mikko Turunen ,

  ¶‡ MT and RD also contibuted equally to this work.

  Affiliation Genome-Scale Biology Program, Research Programs Unit and Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland

  ⨯
• Raquel Diaz ,

  ¶‡ MT and RD also contibuted equally to this work.

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Lauri Lyly,

  Affiliation Genome-Scale Biology Program, Research Programs Unit, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

  ⨯
• Pirita Pekkonen,

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Juha Rantala,

  Affiliation VTT Medical Biotechnology, Turku, Finland

  ⨯
• Krista Ojala,

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Grzegorz Sarek,

  Current address: London Research Institute, Cancer Research UK, Clare Hall Laboratories, South Mimms, United Kingdom

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Mari Teesalu,

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Oxana Denisova,

  Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

  ⨯
• Karita Peltonen,

  Affiliation Centre for Drug Discovery, University of Helsinki, Helsinki, Finland

  ⨯
• Ilkka Julkunen,

  Affiliation Department of Virology, University of Turku and National Institute for Health and Welfare, Turku, Finland

  ⨯
• Markku Varjosalo,

  Affiliation Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland

  ⨯
• Denis Kainov,

  Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

  ⨯
• Olli Kallioniemi,

  Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

  ⨯
• Marikki Laiho,

  Affiliations Centre for Drug Discovery, University of Helsinki, Helsinki, Finland, Department of Radiation Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Jussi Taipale,

  Affiliation Genome-Scale Biology Program, Research Programs Unit and Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland

  ⨯
• Sampsa Hautaniemi,

  Affiliation Genome-Scale Biology Program, Research Programs Unit, University of Helsinki, Biomedicum Helsinki, Helsinki, Finland

  ⨯
•  [ ... ],
• Päivi M. Ojala

  * E-mail: p.ojala@imperial.ac.uk

  Affiliations Translational Cancer Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland, Foundation for the Finnish Cancer Institute, Helsinki, Finland, Section of Virology, Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom

  ⨯
• [ view all ]
• [ view less ]